Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis.

Angel CZ, Iguacel I, Mullee A, Guha N, Wasson R, McKenna DJ, Gunter MJ, Smelov V, Huybrechts I.

Prostate Cancer Prostatic Dis. 2019 May 30. doi: 10.1038/s41391-019-0154-1. [Epub ahead of print]

PMID:
31147627
2.

Time to endoscopy for acute upper gastrointestinal bleeding: Results from a prospective multicentre trainee-led audit.

Siau K, Hodson J, Ingram R, Baxter A, Widlak MM, Sharratt C, Baker GM, Troth T, Hicken B, Tahir F, Magrabi M, Yousaf N, Grant C, Poon D, Khalil H, Lee HL, White JR, Tan H, Samani S, Hooper P, Ahmed S, Amin M, Mahgoub S, Asghar K, Leet F, Harborne MJ, Polewiczowska B, Khan S, Anjum MR, McFarlane M, Mozdiak E, O'Flynn LD, Blee IC, Molyneux RM, Kurian A, Abbas SN, Abbasi A, Karim A, Yasin A, Khattak F, White J, Ahmed R, Morgan JA, Alleyne L, Alam MA, Palaniyappan N, Rodger VJ, Sawhney P, Aslam N, Okeke T, Lawson A, Cheung D, Reid JP, Awasthi A, Anderson MR, Timothy JR, Pattni S, Ahmad S, Townson G, Shearman J, Giljaca V, Brookes MJ, Disney BR, Guha N, Thomas T, Norman A, Wurm P, Shah A, Fisher NC, Ishaq S, Major G.

United European Gastroenterol J. 2019 Mar;7(2):199-209. doi: 10.1177/2050640618811491. Epub 2018 Oct 28.

3.

Welding fumes and lung cancer: a meta-analysis of case-control and cohort studies.

Honaryar MK, Lunn RM, Luce D, Ahrens W, 't Mannetje A, Hansen J, Bouaoun L, Loomis D, Byrnes G, Vilahur N, Stayner L, Guha N.

Occup Environ Med. 2019 Jun;76(6):422-431. doi: 10.1136/oemed-2018-105447. Epub 2019 Apr 4. Review.

PMID:
30948521
4.

Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening.

Mandrik O, Zielonke N, Meheus F, Severens JLH, Guha N, Herrero Acosta R, Murillo R.

Int J Cancer. 2019 Feb 14. doi: 10.1002/ijc.32211. [Epub ahead of print]

PMID:
30762235
5.

Software Tools to Facilitate Systematic Review Used for Cancer Hazard Identification.

Shapiro AJ, Antoni S, Guyton KZ, Lunn RM, Loomis D, Rusyn I, Jahnke GD, Schwingl PJ, Mehta SS, Addington J, Guha N.

Environ Health Perspect. 2018 Oct;126(10):104501. doi: 10.1289/EHP4224.

6.

A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse.

Böhning D, Böhning W, Guha N, Cowan DA, Bartlett C, Sönksen PH, Holt RIG.

BMC Res Notes. 2018 Sep 5;11(1):650. doi: 10.1186/s13104-018-3741-7.

7.

Identifying occupational carcinogens: an update from the IARC Monographs.

Loomis D, Guha N, Hall AL, Straif K.

Occup Environ Med. 2018 Aug;75(8):593-603. doi: 10.1136/oemed-2017-104944. Epub 2018 May 16. Review.

8.

Coffee Drinking and the Risk of Endometrial Cancer: An Updated Meta-Analysis of Observational Studies.

Lukic M, Guha N, Licaj I, van den Brandt PA, Stayner LT, Tavani A, Weiderpass E.

Nutr Cancer. 2018 May-Jun;70(4):513-528. doi: 10.1080/01635581.2018.1460681. Epub 2018 Apr 30.

PMID:
29708405
9.

Cancer mortality in an international cohort of reinforced plastics workers exposed to styrene: a reanalysis.

Loomis D, Guha N, Kogevinas M, Fontana V, Gennaro V, Kolstad HA, McElvenny DM, Sallmén M, Saracci R.

Occup Environ Med. 2019 Mar;76(3):157-162. doi: 10.1136/oemed-2018-105131. Epub 2018 Apr 17.

10.

The IARC Perspective on Colorectal Cancer Screening.

Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K; International Agency for Research on Cancer Handbook Working Group.

N Engl J Med. 2018 May 3;378(18):1734-1740. doi: 10.1056/NEJMsr1714643. Epub 2018 Mar 26. No abstract available.

11.

Neurocognitive deficits in older patients with cancer.

Edwards BJ, Zhang X, Sun M, Holmes HM, Ketonen L, Guha N, Khalil P, Song J, Kesler S, Shah JB, Tripathy D, Valero V, Champlin RE.

J Geriatr Oncol. 2018 Sep;9(5):482-487. doi: 10.1016/j.jgo.2018.02.010. Epub 2018 Mar 9.

PMID:
29530493
12.

Why do endocrine profiles in elite athletes differ between sports?

Sönksen PH, Holt RIG, Böhning W, Guha N, Cowan DA, Bartlett C, Böhning D.

Clin Diabetes Endocrinol. 2018 Feb 7;4:3. doi: 10.1186/s40842-017-0050-3. eCollection 2018.

13.

Hyperandrogenism controversy in elite women's sport: an examination and critique of recent evidence.

Sőnksen PH, Bavington LD, Boehning T, Cowan D, Guha N, Holt R, Karkazis K, Ferguson-Smith MA, Mircetic J, Bőhning D.

Br J Sports Med. 2018 Dec;52(23):1481-1482. doi: 10.1136/bjsports-2017-098446. Epub 2018 Jan 19. No abstract available.

PMID:
29351951
14.

Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detection.

Böhning D, Liu W, Holt RI, Böhning W, Guha N, Sönksen P, Cowan D, Liang T.

Stat Methods Med Res. 2019 Mar;28(3):928-936. doi: 10.1177/0962280217739452. Epub 2017 Nov 16.

PMID:
29145769
15.

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J, Corbett C, Townsend S, Thomas J, Guo K, Hull D, Beard HA, Thompson J, Atkinson A, Bienek C, McGowan N, Guha N, Campbell J, Hollyman D, Stocken D, Yap C, Forbes SJ.

Lancet Gastroenterol Hepatol. 2018 Jan;3(1):25-36. doi: 10.1016/S2468-1253(17)30326-6. Epub 2017 Nov 7.

16.

Carcinogenicity of benzene.

Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Vilahur N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2017 Dec;18(12):1574-1575. doi: 10.1016/S1470-2045(17)30832-X. Epub 2017 Oct 26. No abstract available.

PMID:
29107678
17.

Isolated aortic root dilation in homocystinuria.

Lorenzini M, Guha N, Davison JE, Pitcher A, Pandya B, Kemp H, Lachmann R, Elliott PM, Murphy E.

J Inherit Metab Dis. 2018 Jan;41(1):109-115. doi: 10.1007/s10545-017-0094-7. Epub 2017 Oct 4.

18.

Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice.

Morovat A, Weerasinghe G, Nesbitt V, Hofer M, Agnew T, Quaghebeur G, Sergeant K, Fratter C, Guha N, Mirzazadeh M, Poulton J.

J Clin Med. 2017 Aug 21;6(8). pii: E80. doi: 10.3390/jcm6080080.

19.

Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.

Fang P, Jiang W, Allen P, Glitza I, Guha N, Hwu P, Ghia A, Phan J, Mahajan A, Tawbi H, Li J.

J Neurooncol. 2017 Jul;133(3):595-602. doi: 10.1007/s11060-017-2470-4. Epub 2017 May 12.

PMID:
28500560
20.

Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide.

Guha N, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Vilahur N, Muller K, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2017 May;18(5):581-582. doi: 10.1016/S1470-2045(17)30255-3. Epub 2017 Apr 10. No abstract available.

PMID:
28408286
21.

Erratum to: Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.

Böhning D, Böhning W, Guha N, Cowan DA, Sönksen PH, Holt RI.

BMC Med Res Methodol. 2016 Nov 28;16(1):164. No abstract available.

22.

MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.

Zhang L, Wang J, Wang Y, Zhang Y, Castro P, Shao L, Sreekumar A, Putluri N, Guha N, Deepak S, Padmanaban A, Creighton CJ, Ittmann M.

Cancer Res. 2016 Nov 1;76(21):6290-6298. Epub 2016 Aug 30.

23.

Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.

Böhning D, Böhning W, Guha N, Cowan DA, Sönksen PH, Holt RI.

BMC Med Res Methodol. 2016 Oct 28;16(1):147. Erratum in: BMC Med Res Methodol. 2016 Nov 28;16(1):164.

24.

Carcinogenicity of pentachlorophenol and some related compounds.

Guyton KZ, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2016 Dec;17(12):1637-1638. doi: 10.1016/S1470-2045(16)30513-7. Epub 2016 Oct 23. No abstract available. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711.

PMID:
27784619
25.

Therapeutic drug monitoring in the era of precision medicine: opportunities!

Cremers S, Guha N, Shine B.

Br J Clin Pharmacol. 2016 Oct;82(4):900-2. doi: 10.1111/bcp.13047. No abstract available.

26.

Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps.

Cichocki JA, Guyton KZ, Guha N, Chiu WA, Rusyn I, Lash LH.

J Pharmacol Exp Ther. 2016 Oct;359(1):110-23. doi: 10.1124/jpet.116.232629. Epub 2016 Aug 10. Review.

27.

Carcinogenicity of drinking coffee, mate, and very hot beverages.

Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2016 Jul;17(7):877-878. doi: 10.1016/S1470-2045(16)30239-X. Epub 2016 Jun 15. No abstract available.

PMID:
27318851
28.

Prioritizing Chemicals for Risk Assessment Using Chemoinformatics: Examples from the IARC Monographs on Pesticides.

Guha N, Guyton KZ, Loomis D, Barupal DK.

Environ Health Perspect. 2016 Dec;124(12):1823-1829. Epub 2016 May 10.

29.

Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.

Holt RI, Guha N, Böhning W, Bartlett C, Cowan DA, Sönksen PH, Böhning D.

Drug Test Anal. 2017 Jan;9(1):30-37. doi: 10.1002/dta.1941. Epub 2016 Feb 17.

PMID:
26888146
30.

Earlier Detection And Treatment of Non-Alcoholic Fatty Liver Disease: An Economic Evaluation to Appraise An Innovative Diagnostic Pathway to Detect And Intervene Where There Are Known Risk Factors.

Tanajewski L, Harris R, Harman D, Guha N, Gkountouras G, Berdunov V, Elliott RA.

Value Health. 2015 Nov;18(7):A627. doi: 10.1016/j.jval.2015.09.2208. Epub 2015 Oct 20. No abstract available.

31.

Carcinogenicity of consumption of red and processed meat.

Bouvard V, Loomis D, Guyton KZ, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2015 Dec;16(16):1599-600. doi: 10.1016/S1470-2045(15)00444-1. Epub 2015 Oct 29. No abstract available.

PMID:
26514947
32.

Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.

Barkeer S, Guha N, Hothpet V, Saligrama Adavigowda D, Hegde P, Padmanaban A, Yu LG, Swamy BM, Inamdar SR.

Glycobiology. 2015 Dec;25(12):1375-91. doi: 10.1093/glycob/cwv067. Epub 2015 Sep 7.

PMID:
26347523
33.

Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides.

Schafer JL, Ries M, Guha N, Connole M, Colantonio AD, Wiertz EJ, Wilson NA, Kaur A, Evans DT.

PLoS Pathog. 2015 Sep 2;11(9):e1005145. doi: 10.1371/journal.ppat.1005145. eCollection 2015 Sep.

34.

European Code against Cancer, 4th Edition: Tobacco and cancer.

Leon ME, Peruga A, McNeill A, Kralikova E, Guha N, Minozzi S, Espina C, Schüz J.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S20-33. doi: 10.1016/j.canep.2015.06.001. Epub 2015 Aug 11.

35.

Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid.

Loomis D, Guyton K, Grosse Y, El Ghissasi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France.

Lancet Oncol. 2015 Aug;16(8):891-2. doi: 10.1016/S1470-2045(15)00081-9. Epub 2015 Jun 22. No abstract available.

PMID:
26111929
36.

Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds.

Lauby-Secretan B, Loomis D, Baan R, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Grosse Y, Straif K.

Environ Sci Pollut Res Int. 2016 Feb;23(3):2220-9. doi: 10.1007/s11356-015-4829-4. Epub 2015 Jun 17. Review.

PMID:
26077316
37.

The Effects of Recombinant Human Insulin-Like Growth Factor-I/Insulin-Like Growth Factor Binding Protein-3 Administration on Body Composition and Physical Fitness in Recreational Athletes.

Guha N, Nevitt SP, Francis M, Woodland JA, Böhning D, Sönksen PH, Holt RI.

J Clin Endocrinol Metab. 2015 Aug;100(8):3126-31. doi: 10.1210/jc.2015-1996. Epub 2015 Jun 5.

PMID:
26046967
38.

Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate.

Guyton KZ, Loomis D, Grosse Y, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France.

Lancet Oncol. 2015 May;16(5):490-1. doi: 10.1016/S1470-2045(15)70134-8. Epub 2015 Mar 20. No abstract available.

PMID:
25801782
39.

The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.

Holt RI, Böhning W, Guha N, Bartlett C, Cowan DA, Giraud S, Bassett EE, Sönksen PH, Böhning D.

Drug Test Anal. 2015 Sep;7(9):745-55. doi: 10.1002/dta.1772. Epub 2015 Jan 21.

PMID:
25645199
40.

Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes.

Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2014 Dec;15(13):1427-8. doi: 10.1016/S1470-2045(14)71109-X. Epub 2014 Oct 31. No abstract available.

PMID:
25499275
41.

Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone.

Benbrahim-Tallaa L, Lauby-Secretan B, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2014 Aug;15(9):924-5. No abstract available.

PMID:
25225686
42.

The carcinogenicity of outdoor air pollution.

Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group IARC.

Lancet Oncol. 2013 Dec;14(13):1262-3. No abstract available.

PMID:
25035875
43.

Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis.

Hamra GB, Guha N, Cohen A, Laden F, Raaschou-Nielsen O, Samet JM, Vineis P, Forastiere F, Saldiva P, Yorifuji T, Loomis D.

Environ Health Perspect. 2014 Sep;122(9):906-11. doi: 10.1289/ehp.1408092. Epub 2014 Jun 6. Review. Erratum in: Environ Health Perspect. 2014 Sep;122(9):A236.

44.

Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies.

Vlaanderen J, Straif K, Ruder A, Blair A, Hansen J, Lynge E, Charbotel B, Loomis D, Kauppinen T, Kyyronen P, Pukkala E, Weiderpass E, Guha N.

Environ Health Perspect. 2014 Jul;122(7):661-6. doi: 10.1289/ehp.1307055. Epub 2014 Mar 21. Review.

45.

Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.

Guha N, Erotokritou-Mulligan I, Bartlett C, Nevitt SP, Francis M, Bassett EE, Cowan DA, Sönksen PH, Holt RI.

J Clin Endocrinol Metab. 2014 Jun;99(6):2259-68. doi: 10.1210/jc.2013-3897. Epub 2014 Feb 25.

PMID:
24606087
46.

Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control.

Guha N, Warnakulasuriya S, Vlaanderen J, Straif K.

Int J Cancer. 2014 Sep 15;135(6):1433-43. doi: 10.1002/ijc.28643. Epub 2014 May 14.

47.

Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.

Guha N, Erotokritou-Mulligan I, Nevitt SP, Francis M, Bartlett C, Cowan DA, Bassett EE, Sönksen PH, Holt RI.

Drug Test Anal. 2013 Nov-Dec;5(11-12):843-9. doi: 10.1002/dta.1562. Epub 2013 Oct 31.

PMID:
24173773
48.

Carcinogenicity of some drugs and herbal products.

Grosse Y, Loomis D, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2013 Aug;14(9):807-8. No abstract available.

PMID:
24058961
49.

Assays for GH, IGF-I, and IGF binding protein-3.

Guha N.

Methods Mol Biol. 2013;1065:117-28. doi: 10.1007/978-1-62703-616-0_7.

PMID:
23996360
50.

Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.

Guha N, Cowan DA, Sönksen PH, Holt RI.

Anal Bioanal Chem. 2013 Dec;405(30):9669-83. doi: 10.1007/s00216-013-7229-y. Epub 2013 Aug 11. Review.

PMID:
23934394

Supplemental Content

Support Center